These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 31227562

  • 1. Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy.
    Ikeda S, Koike H, Nishi R, Kawagashira Y, Iijima M, Katsuno M, Sobue G.
    J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):988-996. PubMed ID: 31227562
    [Abstract] [Full Text] [Related]

  • 2. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S, Isose S, Mori M, Mitsuma S, Sawai S, Beppu M, Sekiguchi Y, Misawa S.
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [Abstract] [Full Text] [Related]

  • 3. [Clinical and long-term characteristics of the subtypes of chronic inflammatory demyelinating polyneuropathy].
    Shimizu F, Nemoto J, Takeshita Y, Maeda T, Koga M, Kanda T.
    Rinsho Shinkeigaku; 2022 Mar 29; 62(3):173-177. PubMed ID: 35228460
    [Abstract] [Full Text] [Related]

  • 4. Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes.
    Shimizu F, Sawai S, Sano Y, Beppu M, Misawa S, Nishihara H, Koga M, Kuwabara S, Kanda T.
    PLoS One; 2014 Mar 29; 9(8):e104205. PubMed ID: 25105500
    [Abstract] [Full Text] [Related]

  • 5. Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights into Classification and Therapeutic Strategy.
    Koike H, Katsuno M.
    Neurol Ther; 2020 Dec 29; 9(2):213-227. PubMed ID: 32410146
    [Abstract] [Full Text] [Related]

  • 6. Cranial nerve involvement in typical and atypical chronic inflammatory demyelinating polyneuropathies.
    Shibuya K, Tsuneyama A, Misawa S, Suichi T, Suzuki Y, Kojima Y, Nakamura K, Kano H, Prado M, Kuwabara S.
    Eur J Neurol; 2020 Dec 29; 27(12):2658-2661. PubMed ID: 32876980
    [Abstract] [Full Text] [Related]

  • 7. Different distribution of demyelination in chronic inflammatory demyelinating polyneuropathy subtypes.
    Shibuya K, Tsuneyama A, Misawa S, Sekiguchi Y, Beppu M, Suichi T, Suzuki YI, Nakamura K, Kano H, Kuwabara S.
    J Neuroimmunol; 2020 Apr 15; 341():577170. PubMed ID: 32006783
    [Abstract] [Full Text] [Related]

  • 8. Chronic Inflammatory Demyelinating Polyneuropathy.
    Kuwabara S, Misawa S.
    Adv Exp Med Biol; 2019 Apr 15; 1190():333-343. PubMed ID: 31760654
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy-responsive allodynia due to distal acquired demyelinating symmetric (DADS) neuropathy.
    Liewluck T, Engelstad JK, Mauermann ML.
    Muscle Nerve; 2016 Nov 15; 54(5):973-977. PubMed ID: 27251375
    [Abstract] [Full Text] [Related]

  • 10. Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy.
    Yiannikas C, Vucic S.
    Muscle Nerve; 2008 Nov 15; 38(5):1447-1454. PubMed ID: 18932207
    [Abstract] [Full Text] [Related]

  • 11. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
    Koike H, Kadoya M, Kaida KI, Ikeda S, Kawagashira Y, Iijima M, Kato D, Ogata H, Yamasaki R, Matsukawa N, Kira JI, Katsuno M, Sobue G.
    J Neurol Neurosurg Psychiatry; 2017 Jun 15; 88(6):465-473. PubMed ID: 28073817
    [Abstract] [Full Text] [Related]

  • 12. Research criteria for defining patients with CIDP.
    Sander HW, Latov N.
    Neurology; 2003 Apr 01; 60(8 Suppl 3):S8-15. PubMed ID: 12707417
    [Abstract] [Full Text] [Related]

  • 13. [Recent topics of chronic inflammatory demyelinating polyneuropathy].
    Iijima M.
    Rinsho Shinkeigaku; 2012 Apr 01; 52(11):917-9. PubMed ID: 23196467
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The distribution pattern of nerve enlargement in clinical subtypes of chronic inflammatory demyelinating polyneuropathy.
    Niu J, Zhang L, Hu N, Cui L, Liu M.
    J Neuroimaging; 2024 Apr 01; 34(1):127-137. PubMed ID: 37823703
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy.
    Lozeron P, Mariani LL, Dodet P, Beaudonnet G, Théaudin M, Adam C, Arnulf B, Adams D.
    Neurology; 2018 Jul 10; 91(2):e143-e152. PubMed ID: 29907605
    [Abstract] [Full Text] [Related]

  • 20. Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.
    Shimizu F, Oishi M, Sawai S, Beppu M, Misawa S, Matsui N, Miyashiro A, Maeda T, Takeshita Y, Nishihara H, Sano Y, Sato R, Kaji R, Kuwabara S, Kanda T.
    J Neurol Neurosurg Psychiatry; 2019 Apr 10; 90(4):444-450. PubMed ID: 30523038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.